Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Spansion is protected by AMD/PTSC-Deal as follows
It looks like AMD owns about 38% of their shares, and Fujitsu about 23%. 128 million shares total outstanding.
Share
New Message
Please login to post a reply